US Patent Issued to AMYLOID SOLUTION on Aug. 18 for "Pharmaceutical composition for treating degenerative brain disease, including glycine transporter as active ingredient" (South Korean Inventors)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,708,657, issued on Aug. 18, was assigned to AMYLOID SOLUTION INC. (Seongnam-si, South Korea).

"Pharmaceutical composition for treating degenerative brain disease, including glycine transporter as active ingredient" was invented by Seong Muk Kim (Seoul, South Korea), Seongjeong Park (Yongin-si, South Korea), Hye-ju Kim (Hwaseong-si, South Korea), Youngsoo Kim (Incheon, South Korea) and Hyeyun Kim (Incheon, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided is a pharmaceutical composition for treating a degenerative brain disease, including a glycine transporter as an active ingredient. A composition including, as an active ingredient, a ...